Australia markets open in 6 hours 26 minutes

Zealand Pharma A/S (ZEAL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.81+0.64 (+3.96%)
As of 12:58PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 762.13M
Enterprise value 718.06M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.01
Price/book (mrq)8.17
Enterprise value/revenue 2.38
Enterprise value/EBITDA -0.77

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3-49.19%
S&P500 52-week change 3-16.88%
52-week high 333.42
52-week low 39.93
50-day moving average 317.92
200-day moving average 316.25

Share statistics

Avg vol (3-month) 32.24k
Avg vol (10-day) 31.47k
Shares outstanding 546.12M
Implied shares outstanding 6N/A
Float 836.79M
% held by insiders 10.00%
% held by institutions 11.75%
Shares short (30 Aug 2022) 475.97k
Short ratio (30 Aug 2022) 419.53
Short % of float (30 Aug 2022) 4N/A
Short % of shares outstanding (30 Aug 2022) 40.16%
Shares short (prior month 28 July 2022) 476.46k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin 0.00%
Operating margin (ttm)-327.92%

Management effectiveness

Return on assets (ttm)-37.86%
Return on equity (ttm)-115.45%

Income statement

Revenue (ttm)293.77M
Revenue per share (ttm)6.76
Quarterly revenue growth (yoy)-22.40%
Gross profit (ttm)173.75M
EBITDA -932.54M
Net income avi to common (ttm)-1.09B
Diluted EPS (ttm)-3.26
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)864.44M
Total cash per share (mrq)18.68
Total debt (mrq)485.42M
Total debt/equity (mrq)96.13
Current ratio (mrq)3.83
Book value per share (mrq)10.91

Cash flow statement

Operating cash flow (ttm)-1.06B
Levered free cash flow (ttm)-505.17M